A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
Status:
Recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
Approximately 90 patients, aged 50 to 80 years, with a diagnosis of early Alzheimer's disease
will take part in this research study. This study will be conducted in the US. There will be
3 treatment groups: 2 Active doses and 1 group will receive placebo completely by chance.
Patients, caregiver, Sponsor, nor study staff will know which treatment is assigned. There
are 3 periods in this study: Screening to confirm suitability, Treatment to receive study
medication, and Follow-up to check overall health post-participation